152 related articles for article (PubMed ID: 37370208)
1. Clinicopathologic Features of Noninvasive Inverted Urothelial Papillary Tumor.
Liu Z; Wei S; Tang J
Am J Clin Oncol; 2023 Sep; 46(9):409-413. PubMed ID: 37370208
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic study of 60 cases of urothelial neoplasms with inverted growth patterns: Reclassification by international consultation on urologic disease (ICUD) recommendations.
Bang H; Park H; Park S; Choi E; Cho MS; Sung SH; Choi SY; Cho YM; Jeong SU; Ro JY
Ann Diagn Pathol; 2020 Feb; 44():151433. PubMed ID: 31785538
[TBL] [Abstract][Full Text] [Related]
3. [Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].
Xiao L; Wang CF; Zhu XZ; Yin YL; Chen Y; Lu C; Yu B
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):319-23. PubMed ID: 21756826
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of primary Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) including PUNLMP with inverted growth.
Maxwell JP; Wang C; Wiebe N; Yilmaz A; Trpkov K
Diagn Pathol; 2015 Mar; 10():3. PubMed ID: 25886613
[TBL] [Abstract][Full Text] [Related]
5. The Influence of Inverted Growth Pattern on Recurrence for Patients with Non-Invasive Low Grade Papillary Urothelial Carcinoma of Bladder.
Arslankoz S; Kulaç İ; Ertoy Baydar D
Balkan Med J; 2017 Sep; 34(5):464-468. PubMed ID: 28443589
[TBL] [Abstract][Full Text] [Related]
6. High-grade papillary urothelial carcinoma of the urinary tract: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center.
Chaux A; Karram S; Miller JS; Fajardo DA; Lee TK; Miyamoto H; Netto GJ
Hum Pathol; 2012 Jan; 43(1):115-20. PubMed ID: 21820145
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive papillary urothelial neoplasia (NIPUN): Renaming cancer.
Jones TD; Cheng L
Urol Oncol; 2021 May; 39(5):286-290. PubMed ID: 35550107
[TBL] [Abstract][Full Text] [Related]
8. Inverted urothelial papilloma: is ploidy, MIB-1 proliferative activity, or p53 protein accumulation predictive of urothelial carcinoma?
Cheville JC; Wu K; Sebo TJ; Cheng L; Riehle D; Lohse CM; Shane V
Cancer; 2000 Feb; 88(3):632-6. PubMed ID: 10649258
[TBL] [Abstract][Full Text] [Related]
9. Inverted urothelial papilloma of the urinary bladder with focal papillary pattern: a previously undescribed feature.
Albores-Saavedra J; Chable-Montero F; Hernández-Rodríguez OX; Montante-Montes de Oca D; Angeles-Angeles A
Ann Diagn Pathol; 2009 Jun; 13(3):158-61. PubMed ID: 19433293
[TBL] [Abstract][Full Text] [Related]
10. Histologic grading of urothelial carcinoma: a reappraisal.
Cheng L; MacLennan GT; Lopez-Beltran A
Hum Pathol; 2012 Dec; 43(12):2097-108. PubMed ID: 22542126
[TBL] [Abstract][Full Text] [Related]
11. Low-grade papillary urothelial carcinoma of the urinary bladder: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center.
Miyamoto H; Brimo F; Schultz L; Ye H; Miller JS; Fajardo DA; Lee TK; Epstein JI; Netto GJ
Arch Pathol Lab Med; 2010 Aug; 134(8):1160-3. PubMed ID: 20670136
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic features and prognostic significance of mixed (Low and high-grade) papillary urothelial carcinoma comparison with low and high-grade papillary urothelial carcinoma.
Kir G; Cecikoglu GE; Topal CS; Sorkun MH; Culpan M; Suceken FY; Karaca H; Yildirim A
Virchows Arch; 2023 Nov; 483(5):621-634. PubMed ID: 37632533
[TBL] [Abstract][Full Text] [Related]
13. Invasive high-grade urothelial carcinoma of the bladder, renal pelvis, ureter, and prostatic urethra arising in a background of urothelial carcinoma with an inverted growth pattern: a contemporary clinicopathological analysis of 91 cases.
Gutierrez CM; Alemozaffar M; Osunkoya AO
Hum Pathol; 2019 Oct; 92():18-24. PubMed ID: 31351154
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
[TBL] [Abstract][Full Text] [Related]
15. A retrospective study on expression and clinical significance of PHH3, Ki67 and P53 in bladder exophytic papillary urothelial neoplasms.
Qi G; Liu J; Tao S; Fan W; Zheng H; Wang M; Yang H; Liu Y; Liu H; Zhou F
PeerJ; 2023; 11():e15675. PubMed ID: 37456895
[TBL] [Abstract][Full Text] [Related]
16. Urothelial tumors of the urinary bladder in young patients: a clinicopathologic study of 59 cases.
Stanton ML; Xiao L; Czerniak BA; Guo CC
Arch Pathol Lab Med; 2013 Oct; 137(10):1337-41. PubMed ID: 24079760
[TBL] [Abstract][Full Text] [Related]
17. [Significance of TERT promoter mutation in differential diagnosis of non-invasive inverted urothelial lesions of bladder].
Zhang YH; Xie JJ; Wang JG; Wang Y; Zhan XH; Gao J; He HY
Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1216-1222. PubMed ID: 38058037
[No Abstract] [Full Text] [Related]
18. Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?
Hentschel AE; van Rhijn BWG; Bründl J; Compérat EM; Plass K; Rodríguez O; Henríquez JDS; Hernández V; de la Peña E; Alemany I; Turturica D; Pisano F; Soria F; Čapoun O; Bauerová L; Pešl M; Bruins HM; Runneboom W; Herdegen S; Breyer J; Brisuda A; Scavarda-Lamberti A; Calatrava A; Rubio-Briones J; Seles M; Mannweiler S; Bosschieter J; Kusuma VRM; Ashabere D; Huebner N; Cotte J; Mertens LS; Cohen D; Lunelli L; Cussenot O; Sheikh SE; Volanis D; Coté JF; Rouprêt M; Haitel A; Shariat SF; Mostafid AH; Nieuwenhuijzen JA; Zigeuner R; Dominguez-Escrig JL; Hacek J; Zlotta AR; Burger M; Evert M; Hulsbergen-van de Kaa CA; van der Heijden AG; Kiemeney LALM; Soukup V; Molinaro L; Gontero P; Llorente C; Algaba F; Palou J; N'Dow J; Babjuk M; van der Kwast TH; Sylvester RJ
Urol Oncol; 2020 May; 38(5):440-448. PubMed ID: 31704141
[TBL] [Abstract][Full Text] [Related]
19. The pathology of urinary bladder lesions with an inverted growth pattern.
Guo A; Liu A; Teng X
Chin J Cancer Res; 2016 Feb; 28(1):107-21. PubMed ID: 27041933
[TBL] [Abstract][Full Text] [Related]
20. Biological significance of TERT promoter mutation in papillary urothelial neoplasm of low malignant potential.
Wang CC; Huang CY; Jhuang YL; Chen CC; Jeng YM
Histopathology; 2018 Apr; 72(5):795-803. PubMed ID: 29193225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
